PT2456889E - Marcadores para o cancro do endométrio - Google Patents

Marcadores para o cancro do endométrio Download PDF

Info

Publication number
PT2456889E
PT2456889E PT107369902T PT10736990T PT2456889E PT 2456889 E PT2456889 E PT 2456889E PT 107369902 T PT107369902 T PT 107369902T PT 10736990 T PT10736990 T PT 10736990T PT 2456889 E PT2456889 E PT 2456889E
Authority
PT
Portugal
Prior art keywords
markers
endometric
cancer
endometric cancer
Prior art date
Application number
PT107369902T
Other languages
English (en)
Portuguese (pt)
Inventor
Miguel Abal Posada
Andreas Doll
Antonio Gil Moreno
Cristina Perez
Elisabet Rossell
Tamara Maes
Jaumereventós Puigjaner
Original Assignee
Geadic Biotec Aie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geadic Biotec Aie filed Critical Geadic Biotec Aie
Publication of PT2456889E publication Critical patent/PT2456889E/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5755—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the uterine cervix, uterine corpus or endometrium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT107369902T 2009-07-24 2010-07-23 Marcadores para o cancro do endométrio PT2456889E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09166398 2009-07-24

Publications (1)

Publication Number Publication Date
PT2456889E true PT2456889E (pt) 2014-11-21

Family

ID=42751506

Family Applications (1)

Application Number Title Priority Date Filing Date
PT107369902T PT2456889E (pt) 2009-07-24 2010-07-23 Marcadores para o cancro do endométrio

Country Status (17)

Country Link
US (2) US9046522B2 (enExample)
EP (2) EP2456889B1 (enExample)
JP (1) JP5934093B2 (enExample)
KR (1) KR101828290B1 (enExample)
CN (2) CN105132529A (enExample)
AU (1) AU2010275699B2 (enExample)
BR (1) BR112012001469B1 (enExample)
CA (1) CA2767914C (enExample)
DK (1) DK2456889T3 (enExample)
ES (2) ES2523683T3 (enExample)
HR (1) HRP20141062T1 (enExample)
IN (1) IN2012DN00707A (enExample)
MX (1) MX2012000921A (enExample)
PL (1) PL2456889T3 (enExample)
PT (1) PT2456889E (enExample)
RU (1) RU2596394C2 (enExample)
WO (1) WO2011009637A2 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105132529A (zh) * 2009-07-24 2015-12-09 吉第克生物技术有限公司 子宫内膜癌的标记物
CN107389936A (zh) * 2011-09-22 2017-11-24 斯隆-凯特林纪念癌症中心 检测卵巢癌
EP2787350A1 (en) * 2013-04-05 2014-10-08 Atlas Antibodies AB ASRGL1 in endometrial cancer
KR102113310B1 (ko) * 2013-09-03 2020-05-20 아주대학교 산학협력단 암 세포 분리용 조성물, 키트 및 이를 이용한 분리 방법
AU2015302059B2 (en) 2014-08-12 2020-02-06 Nextgen Jane, Inc. System and method for monitoring health based on collected bodily fluid
KR20170055540A (ko) * 2014-09-17 2017-05-19 메르크 파텐트 게엠베하 뼈 전이 질환 치료 방법, 그에 따른 약제, 및 뼈 전이 질환 치료의 임상 결과 예측 방법
CN107102141A (zh) * 2016-02-23 2017-08-29 中国科学院生物物理研究所 分子标记物cd71及在子宫内膜癌诊断、分期及预后中的应用
EP3442706B1 (en) 2016-04-13 2025-07-23 NextGen Jane, Inc. Sample collection and preservation methods
PT3452829T (pt) * 2016-05-04 2024-03-22 Fundacio Hospital Univ Vall Dhebron Institut De Recerca Perm como marcador de cancro endometrial
GB201702392D0 (en) * 2017-02-14 2017-03-29 Univ Edinburgh Methods for cancer diagnosis using a gene expression signature
CN108732351A (zh) * 2017-04-20 2018-11-02 中国科学院上海生命科学研究院 Eps8l2作为指示肝内结节及早期预警肝癌的生物标志物
CN108732350A (zh) * 2017-04-20 2018-11-02 中国科学院上海生命科学研究院 Pla2g6作为指示肝内结节及早期预警肝癌的生物标志物
CN108732349A (zh) * 2017-04-20 2018-11-02 中国科学院上海生命科学研究院 Lta4h作为指示肝内结节及早期预警肝癌的生物标志物
CN109085359A (zh) * 2017-06-13 2018-12-25 中国医学科学院肿瘤医院 血清蛋白标志物组合在结直肠癌筛查和诊治中的应用
PL3655778T3 (pl) * 2017-07-21 2023-09-18 Fundació Hospital Universitari Vall D'hebron - Institut De Recerca Agryna jako marker raka endometrium
AU2019285572B2 (en) * 2018-06-13 2024-09-12 23Ikigai Pte Ltd Method for analysing pluripotent stem cell biomarkers, and implementations thereof
CN109097462B (zh) * 2018-09-10 2022-01-11 青岛市海慈医疗集团 Ap1m2基因作为诊断青光眼的分子标志物的应用
WO2020130190A1 (ko) * 2018-12-20 2020-06-25 경상대학교병원 신장암의 발병 위험성 예측 또는 진단을 위한 정보제공방법
WO2020152679A1 (en) * 2019-01-23 2020-07-30 Gina-Life Diagnostics Ltd. Cancer diagnosis and monitoring apparatus, systems and methods thereof
CN109797217A (zh) * 2019-03-27 2019-05-24 河北医科大学第二医院 帕金森生物标志物及其在制备检测产品中的应用
CN109811058B (zh) * 2019-03-31 2021-11-12 青岛泱深生物医药有限公司 与宫颈疾病发生发展相关的生物标志物及其应用
JP7714535B2 (ja) 2019-10-18 2025-07-29 アムニオティクス・アーベー 羊水およびそれに由来する細胞から羊水間葉系幹細胞を得るためのプロセスならびに装置
US20240218454A1 (en) * 2021-04-22 2024-07-04 H. Lee Moffitt Cancer Center And Research Institute, Inc. Diagnostic to support clinical trial matching and exploratory biomarker analyses in cancer patients
CN114317750B (zh) * 2021-12-29 2024-05-14 上海市第十人民医院 一种卵巢癌生物标志物及其在制备用于卵巢癌腹水转移疾病的药物或试剂盒中的应用
KR102584898B1 (ko) * 2022-10-24 2023-10-04 연세대학교 산학협력단 자궁내막암 진단 방법 및 이를 이용한 키트
WO2024192014A1 (en) * 2023-03-12 2024-09-19 Novelna Inc. Endometrial cancer detection proteins and methods of use thereof

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
AUPO573697A0 (en) * 1997-03-20 1997-04-10 Prince Henry's Institute Of Medical Research Diagnosis of endometrial cancer
US7014996B1 (en) * 1998-10-02 2006-03-21 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers
AUPQ219799A0 (en) 1999-08-13 1999-09-02 R. Lurie Pty Ltd Apparatus for obtaining potological samples
US6884578B2 (en) * 2000-03-31 2005-04-26 Affymetrix, Inc. Genes differentially expressed in secretory versus proliferative endometrium
RU2232397C2 (ru) * 2002-04-03 2004-07-10 НИИ онкологии им. проф. Н.Н. Петрова Способ ранней диагностики патологических состояний эндометрия
WO2004005891A2 (en) * 2002-07-10 2004-01-15 The Regents Of The University Of Michigan Expression profile of lung cancer
WO2004105573A2 (en) * 2003-05-21 2004-12-09 The Wistar Institute Of Anatomy And Biology Method of diagnosis of cancer based on gene expression profiles in cells
EP1670908A2 (en) * 2003-10-02 2006-06-21 Xantos Biomedicine AG Medical use of tbk-1 or of inhibitors thereof
JP5629894B2 (ja) 2004-12-07 2014-11-26 国立大学法人大阪大学 甲状腺乳頭癌を診断するための新規のマーカー
US7998695B2 (en) * 2005-02-10 2011-08-16 Oncotherapy Science, Inc. Method of diagnosing bladder cancer
CN101304736A (zh) * 2005-09-07 2008-11-12 雪兰诺实验室公司 治疗子宫内膜异位症的ikk抑制剂
US20070134687A1 (en) * 2005-09-12 2007-06-14 Aurelium Biopharma Inc. Focused microarray and methods of diagnosing cancer
SG169395A1 (en) * 2006-02-09 2011-03-30 Univ South Florida Detection of cancer by elevated levels of bcl-2
US20070287158A1 (en) * 2006-06-09 2007-12-13 George Gorodeski Cell collection and disease screening
EP1978106A1 (en) * 2007-04-07 2008-10-08 Universitätsklinikum Hamburg-Eppendorf Detection of ESR1 amplification in endometrium cancer and ovary cancer
WO2008137591A2 (en) * 2007-05-02 2008-11-13 Biocept, Inc. Non-invasive detection of endometrial cancer
JP5419195B2 (ja) 2007-08-03 2014-02-19 国立大学法人愛媛大学 頭頸部癌の腫瘍マーカー
US20110136123A1 (en) 2007-08-15 2011-06-09 Universite De Sherbrooke Alternative splicing gene variants in cancer
US8053198B2 (en) * 2007-09-14 2011-11-08 Meso Scale Technologies, Llc Diagnostic methods
WO2009126969A2 (en) * 2008-04-11 2009-10-15 Expression Pathology Inc. Biomarkers for endometrial disease
CN105132529A (zh) * 2009-07-24 2015-12-09 吉第克生物技术有限公司 子宫内膜癌的标记物

Also Published As

Publication number Publication date
CN102549169A (zh) 2012-07-04
DK2456889T3 (en) 2014-12-01
RU2596394C2 (ru) 2016-09-10
EP2848700A1 (en) 2015-03-18
US20150337392A1 (en) 2015-11-26
EP2848700B1 (en) 2017-10-04
ES2654340T3 (es) 2018-02-13
US20120122726A1 (en) 2012-05-17
CN102549169B (zh) 2016-02-24
WO2011009637A3 (en) 2011-04-14
KR101828290B1 (ko) 2018-02-12
IN2012DN00707A (enExample) 2015-06-19
MX2012000921A (es) 2012-06-12
WO2011009637A2 (en) 2011-01-27
US9046522B2 (en) 2015-06-02
EP2456889B1 (en) 2014-09-03
CA2767914A1 (en) 2011-01-27
AU2010275699B2 (en) 2016-06-16
ES2523683T3 (es) 2014-11-28
BR112012001469A2 (pt) 2020-08-11
JP5934093B2 (ja) 2016-06-15
KR20120047334A (ko) 2012-05-11
AU2010275699A1 (en) 2012-02-02
RU2012106432A (ru) 2013-08-27
CN105132529A (zh) 2015-12-09
JP2013500001A (ja) 2013-01-07
PL2456889T3 (pl) 2015-02-27
CA2767914C (en) 2020-02-25
HRP20141062T1 (hr) 2015-01-02
BR112012001469B1 (pt) 2021-08-10
EP2456889A2 (en) 2012-05-30

Similar Documents

Publication Publication Date Title
BRPI1013082A2 (pt) marcadores de risco para enfermidade cardiovascular
BRPI0810984A2 (pt) Micro-descanso extendido para comunicação
FI20095373L (fi) Antenni
PT2515855E (pt) Terapêutica de combinação para dpoc
EP2382331A4 (en) KREBSBIOMARKER
EP2115162A4 (en) Adrb2 cancer markers
EP2625292A4 (en) KREBSBIOMARKER
BRPI1013618A2 (pt) pirimidinas substituídas para o tratamento de câncer
BRPI0812818A2 (pt) Turbo-reator para aeronave
EP2396853A4 (en) ANTENNA
BRPI1013141A2 (pt) novos marcadores selecionaveis rigorosos
EP2283862A4 (en) CANCER AGENT
BRPI1010874A8 (pt) composição para o tratamento de câncer de próstata
BRPI0812040A2 (pt) Indicações para terapia de anti-il-i-beta
BRPI1007995A2 (pt) orto-aminoamidas para o tratamento de cãncer.
FI20085907A0 (fi) Antenniyhdistelmä
FI20095468A0 (fi) Antenniyhdistelmä
FI20095085A0 (fi) Moniresonanssiantenni
BRPI1009063A2 (pt) transceptor multibanda
BR112012028957A2 (pt) métodos para selecionar marcadores de metilação
FI20075275A0 (fi) RF-transkonduktanssituloaste
BRPI0918508A2 (pt) orto-aminoanilidas para o tratamento de câncer
EP2501845A4 (en) KREBSBIOMARKER
BRPI1008993A2 (pt) marcadores fecais
ES1064720Y (es) Guia para persiana